Myths and proofs of angiosome applications in CLI: Where do we stand?

Journal of Endovascular Therapy

Volumn 21, Issue 5, 2014, Pages 616-624

  Alexandrescu, Vlad Adrian ^a  

^a Princess Paola Hospital   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERY RECONSTRUCTION; CRITICAL LIMB ISCHEMIA; FOOT ULCER; HUMAN; META ANALYSIS (TOPIC); MICROANGIOPATHY; MICROCIRCULATION; NOTE; PRESERVATION; REVASCULARIZATION; TISSUE REGENERATION; WOUND HEALING; FEMALE; ISCHEMIA; LEG; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POPLITEAL ARTERY; PROCEDURES; VASCULARIZATION;

ANGIOPLASTY, BALLOON; FEMALE; HUMANS; ISCHEMIA; LOWER EXTREMITY; MALE; POPLITEAL ARTERY;

EID: 84908118908     PISSN: 15266028     EISSN: 15451550     Source Type: Journal    
DOI: 10.1583/14-4692C.1     Document Type: Note

References (46)

1. Taylor GI, Palmer JH. The vascular territories (angiosomes) of the body: experimental studies and clinical applications. Br J Plast Surg. 1987;40:113-141.
2. Attinger CE, Evans KK, Bulan E, et al. Angiosomes of the foot and ankle and clinical implications for limb salvage: reconstruction, incisions and revascularization. Plast Reconstr Surg. 2006;117(7 Suppl):261S-293S.
3. Alexandrescu V, Hubermont G, Philips Y, et al. Selective angioplasty following an angiosome model of reperfusion in the treatment of Wagner 1-4 diabetic foot lesions: practice in a multidisciplinary diabetic limb service. J Endovasc Ther. 2008;15:580-593.
4. Varela C, Acin NF, Haro JD, et al. The role of foot collateral vessels on ulcer healing and limb salvage after successful endovascular and surgical distal procedures according to an angiosome model. Vasc Endovasc Surg. 2010;44:654-660.
5. Neville RF, Attinger CE, Bulan EJ, et al. Revascularization of a specific angiosome for limb salvage: does the target artery matter? Ann Vasc Surg. 2009;23:367-373.
6. Iida O, Nanto S, Uematsu M, et al. Importance of the angiosome concept for endovascular therapy in patients with critical limb ischemia. Catheter Cardiovasc Interv. 2010;75:830-836.
7. Söderström M, Albäck A, Biancari F, et al. Angiosome-targeted infrapopliteal endovascular revascularization for treatment of diabetic foot ulcers. J Vasc Surg. 2013;57:427-435.
8. Alexandrescu V, Vincent G, Azdad K, et al. A reliable approach to diabetic neuroischemic foot wounds: below-the-knee angiosome-oriented angioplasty. J Endovasc Ther. 2011;18:376-387.
9. Biancari F, Juvonen T. Angiosome-targeted lower limb revascularization for ischemic foot wounds: systematic review and meta-analysis. Eur J Vasc Endovasc Surg. 2014;47:517-522.
10. Iida O, Takahara M, Soga Y, et al. Impact of angiosome-oriented revascularization on clinical outcomes in patients with critical limb ischemia without concurrent wound infection and diabetes mellitus. J Endovasc Ther. 2014;21:607-615.
11. Young PM, Gerber TC, Williamson EE, et al. Cardiac I\imaging: part 2, normal, variant and anomalous configurations of the coronary vasculature. AJR Am J Roentgenol. 2011;4:816-826.
12. Hong MK, Pan WR, Wallace D, et al. The angiosome territories of the spinal cord: exploring the issue of preoperative spinal angiography. Laboratory investigation. J Neurosurg Spine. 2008;4:352-364.
13. Yin ZX, Peng TH, Ding HM, et al. Three-dimensional visualization of the cutaneous angiosome by using angiography. Clin Anat. 2013;26:282-287.
14. Rashid H, Slim H, Zayed H, et al. The impact of arterial pedal arch quality and angiosome revascularization on foot tissue loss healing and infrapopliteal bypass outcome. J Vasc Surg. 2013;57:1219-1226.
15. Osawa S, Terashi H, Tsuji Y, et al. Importance of the six angiosome concept through arterialarterial connections in CLI. Int Angiol. 2013;32:375-385.
16. Alexandrescu V. The angiosome concept: anatomical background and physiopathological landmarks in CLI. In: Angiosomes Applications in Critical Limb Ischemia: In Search for Relevance. Torino, Italy: Edizioni Minerva Medica. 2012;1-30, 71-88.
17. Kret MR, Cheng D, Azarbal AF, et al. Utility of direct angiosome revascularization and run-off scores in predicting outcomes in patients undergoing revascularization for critical limb ischemia. J Vasc Surg. 2013;13:1260-1263.
18. Lejay A, Georg Y, Tartaglia E, et al. Long-term outcomes of direct and indirect below-the-knee open revascularization based on the angiosome concept in diabetic patients with critical limb ischemia. Ann Vasc Surg. 2014;28:983-989.
19. Kabra A, Suresh KR, Vivekanand V, et al. Outcomes of angiosome and non-angiosome targeted revascularization in critical lower limb ischemia. J Vasc Surg. 2013;57:44-49.
20. Sumpio BE, Forsythe RO, Ziegler KR, et al. Clinical implications of the angiosome model in peripheral vascular disease. J Vasc Surg. 2013;58:814-826.
21. Bosanquet DC, Glasbey JC, Williams IM, et al. Systematic review and meta-analysis of direct versus indirect angiosomal revascularization of infrapopliteal arteries. Eur J Vasc Endovasc Surg. 2014;48:88-97.
22. Houlind K, Christensen J, Hallenberg C, et al. Early results from an angiosome-directed open surgical technique for venous arterialization in patients with critical lower limb ischemia. Diabet Foot Ankle. 2013;17:1-5.
23. Alexandrescu V, Ngongang C, Vincent G, et al. Deep calf veins arterialization for inferior limb preservation in diabetic patients with extended ischaemic wounds, unfit for direct arterial reconstruction: preliminary results according to an angiosome model of perfusion. Cardiovasc Revasc Med. 2011;12:10-19.
24. Alexandrescu V. Is limb loss always inevitable for critical neuro-ischemic foot wounds in diabetic patients with end stage renal disease and unfit for vascular reconstructions? In: Diseases of Renal Parenchyma. Sahay M, ed. Rijeka, Croatia: InTech Open Science; 2012:228-246.
25. Azuma N, Uchida H, Kokubo T, et al. Factors influencing wound healing of critical ischaemic foot after bypass surgery: is the angiosome important in selecting bypass target artery? Eur J Vasc Endovasc Surg. 2012;43:322-328.
26. Blanes O, Riera V, Puigmacia L, et al. Percutaneous revascularization of specific angiosome in critical limb ischemia. Angeologia. 2011;63:11-17.
27. Fossaceca R, Guzzardi G, Cerini P, et al. Endovascular treatment of diabetic foot in a selected population of patients with below-theknee disease: is the angiosome model effective? Cardiovasc Intervent Radiol. 2013;36:637-644.
28. Alexandrescu VA. Is the angiosome concept useful ? Vascular and Endovascular Controversies Update. 2012; London: Biba Publ. Ltd; 2012:469-482.
29. Iida O, Soga Y, Hirano K, et al. Long-term results of direct and indirect endovascular revascularization based on the angiosome concept in patients with critical limb ischemia presenting below-the-knee lesions. J Vasc Surg. 2012;55:363-370.
30. Iida O, Takahara M, Soga Y, et al. Worse limb prognosis for indirect versus direct endovascular revascularization only in patients with critical limb ischemia complicated with wound infection and diabetes mellitus. Eur J Vasc Endovasc Surg. 2013;46:575-582.
31. O'Neal LW. Surgical pathology of the foot and clinicopathologic correlations. In: Levin and O'Neal's The Diabetic Foot. Philadelphia: Mosby Elsevier; 2008:367-401.
32. Kagaya Y, Ohura H, Suga H, et al. Real angiosome assessment from peripheral tissue perfusion using tissue oxygen saturation footmapping in patients with critical limb ischemia. Eur J Vasc Endovasc Surg. 2014;47:433-441.
33. Aerden D, Denecker N, Gallala S, et al. Wound morphology and topography in the diabetic foot: hurdles in implementing angiosomeguided revascularization. Int J Vasc Med. 2014;2:1-5.
34. Ziegler MA, Distasi MR, Bills RG, et al. Marvels, mysteries and misconceptions of vascular compensation to peripheral artery occlusion. Microcirculation 2010;17:3-20.
35. Kawarada O, Yokoi Y, Higashimori A, et al. Assessment of macro- and microcirculation in contemporary critical limb ischemia. Catheter Cardiovasc Interv. 2011;78:1051-1058.
36. Jorneskog G. Why critical limb ischemia criteria are not applicable to diabetic foot and what the consequences are. Scand J Surg. 2012;101:114-118.
37. Yamada T, Gloviczki P, Bower, et al. Variations of the arterial anatomy of the foot. Am J Surg. 1993;166:130-135.
38. Jens S, Koelemay MJ, Reekers J, et al. Diagnostic performance of computed tomography angiography and contrast-enhanced magnetic resonance angiography in patients with critical limb ischaemia and intermittent claudication: systematic review and meta-analysis. Eur Radiol. 2013;3:3104-3114.
39. Utsunomiya M, Nakamura M, Nakanishi M, et al. Impact of wound blush as an angiographic end point of endovascular therapy for patients with critical limb ischemia. J Vasc Surg. 2012;55:113-121.
40. Yamamoto M, Orihashi K, Nishimori H, et al. Indocyanine green angiography for intra-operative assessment in vascular surgery. Eur J Vasc Endovasc Surg. 2012;43:426-432.
41. Yang C, Weng H, Chen L, et al. Transcutaneous oxygen pressure measurement in diabetic foot ulcers: mean values and cut-point for wound healing. J Wound Ostomy Continence Nurs. 2013;40:585-589.
42. Palestro CJ, Love C. Nuclear medicine and diabetic foot infections. Semin Nucl Med. 2009;39:52-65.
43. Orbay H, Hong H, Zhang Y, et al. PET/SPECT imaging of hindlimb ischemia: focusing on angiogenesis and blood flow. Angiogenesis. 2013;16:279-287.
44. Marre F, Sibille L, Nalda E, et al. (18) F-FDG PET/CT imaging of critical ischemia in the diabetic foot. Clin Nucl Med. 2013;38:269-271.
45. Acin F, Varela C, de Maturana IL, et al. Results of infrapopliteal endovascular procedures performed in diabetic patients with critical limb ischemia and tissue loss from the perspective of an angiosome-oriented revascularization strategy. Intern J Vasc Med. 2014;10:2-15.
46. rd ed Simep Publ. Masson; 1995:69-107.